Dr. Lisa Tannock, MD is Professor and Chief of the Division of Endocrinology and Molecular Medicine at the University of Kentucky, and a VA staff physician. She obtained her MD and Internal Medicine training at the University of Toronto, Canada, then completed a fellowship in Metabolism, Endocrinology and Nutrition at the University of Washington. She is a physician-scientist with clinical, educational and research activities.
As a clinician, Dr. Tannock has a primary focus on the care of individuals with or at risk for diabetes, hyperlipidemia and cardiovascular disease. Her research activity reflects this clinical interest, with current funded studies investigating the impact of post-prandial lipid metabolism on chronic inflammation and cardiovascular disease; the impact of triglycerides on HDL levels and function in metabolic syndrome; and the role of serum amyloid A on atherosclerosis development. Dr. Tannock’s research comprises basic biomedical research, use of animal models, and clinical studies. She has served as a mentor to numerous trainees at all levels of training and the majority of her publications are co-authored by these trainees. Dr. Tannock is currently the chair of the Endocrine Society Self Assessment committee.
EBR/CEU Disclosures